ValuEngine upgraded shares of Prana Biotechnology (NASDAQ:PRAN) from a hold rating to a buy rating in a report published on Thursday.
Prana Biotechnology stock traded up $0.05 during trading hours on Thursday, reaching $1.93. 36,165 shares of the stock were exchanged, compared to its average volume of 39,017. Prana Biotechnology has a 52-week low of $1.75 and a 52-week high of $3.79.
About Prana Biotechnology
See Also: Penny Stocks, Risk and Reward Factors
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Prana Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prana Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.